Bullen, Alexander L.
Katz, Ronit
Poursadrolah, Sayna
Short, Samuel A. P.
Long, D. Leann
Cheung, Katharine L.
Sharma, Shilpa
Al-Rousan, Tala
Fregoso, Alma
Schulte, Janin
Gutierrez, Orlando M.
Shlipak, Michael G.
Cushman, Mary
Ix, Joachim H.
Rifkin, Dena E.
Funding for this research was provided by:
U.S. Department of Veterans Affairs (IK2BX004986)
National Institute of Diabetes and Digestive and Kidney Diseases (K24DK110427)
Article History
Received: 11 April 2023
Accepted: 7 December 2023
First Online: 10 January 2024
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. This study protocol was reviewed and approved by the UC San Diego Institutional Review Board (Approval No.: 201856) and complies with the principles of Declaration of Helsinki. All participants provided verbal informed consent before the telephone interview and written informed consent before completing the in-home study visit.
: No patient/participant identifiable data was used for this study. The manuscript was reviewed by the REGARDS Publication Committee who authorized it for publication.
: JS is employed by SphingoTec GmbH, the manufacturer of the PENK-A immunoassay. OG has received grant funding and honoraria from Amgen and Akebia; grant funding from GSK; honoraria from AstraZeneca, Reata and Ardelyx; and serves on a Data Monitoring Committee for QED Therapeutics. MGS receives research funding from Bayer, Inc. MGS reports honoraria from Bayer, Inc., Boehringer Ingelheim, and AstraZeneca, and previously served as a consultant to Cricket Health and Intercept Pharmaceuticals. OG reports receiving grant funding and honoraria from Amgen and Akebia; grant support from GSK; honoraria from AstraZeneca, Reata, and Ardelyx, and serving on the Data Monitoring Committee for QED therapeutics. JI reports receiving grant funding from Baxter International, honoraria from Akebia, Ardelyx, AstraZeneca, and Bayer, and serving on a Data Monitoring Committee for Sanifit International. DLL has received investigator-initiated research support from Amgen, Inc. for work unrelated to current manuscript.The rest of the authors deny any competing interests.